Tamoxifen poor metabolizer

Oct 15, 2021 · Globally, normal and IM phenotypes are the most common. Tamoxifen: CYP2D6: intermediate or poor metabolizers: Results in lower systemic active metabolite Jan 11, 2021 · Abstract

2024-03-29
    Omeprazole and kidney pain
  1. PDF
  2. 4 reported that 24% of patients
  3. In contrast, ultrarapid
  4. Results
  5. 3% (n=64) patients were extensive metabolizers and 36